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Rapidly progressing, painful, ulcerative changes in long-standing psoriasiform
plaques in a 46-year-old manFigure 2 Erosive and fungating lesions on the soles of the feet. (A) At presentation.
(B,C) Ten days before the initiation of chemotherapy. (C) Four months after
chemotherapy.Case report
A 46-year-old man was admitted to a community hospital with
fever and rapidly progressing, painful, ulcerative skin lesions. He
was transferred to our hospital for further examination. According
to his medical history, he had been diagnosed with psoriasis, but
this was not conﬁrmed by a skin biopsy. The generalized pruritic
plaques on his trunk and extremities had waxed and waned for
several years but had exacerbated during the previous year. Skin
examination on admission showed diffuse redness with periorbital,
paranasal, and perioral sparing with multiple coalescent annular
plaques on the trunk and extremities. Some of these lesions were
indurated, others were crusted. Ulcerative plaques were present
on the dorsum of the patient’s right hand and soles (Figures 1A
and 2A). A few inguinal lymph nodes were palpable on each side.
The histopathological examination of specimens obtained from
his left elbow, left thigh, and an inguinal lymph node revealed
dense inﬁltrations of atypical medium-sized lymphocytes with
nuclear pleomorphism. Eosinophils were identiﬁed in the dermis
(Figure 3) of the specimens from the elbow and thigh and in the
perifollicular zones of the lymph node. Immunohistochemical
staining showed that these inﬁltrates were positive for CD2, CD3,
CD4, CD5, CD8, and CD30 and negative for CD10, CD20, CD21,
CD23, Epithelial Membrane Antigen (EMA), and Anaplastic
Lymphoma Kinase (ALK). In situ hybridization for Epstein-Barr
virus-encoded RNA (EBER) produced negative ﬁndings. Other
signiﬁcant laboratory data included the following: white cell count,
23,410 cells/mL (normal: 3500–9100/mL); band form, 35% (normal:
0–3%); total Immunoglobulin E (IgE), 574 IU/mL (normal for adults:
<87 IU/mL); LDH, 461 U/L (normal: 98–192 U/L); ferritin, 387.3 ng/
mL (normal for men: 23.9–336.2 ng/mL). The results of the bone
marrow biopsy were normal. Abdominal computed tomography
(CT) and bone scan revealed the lack of involvement in the internalFigure 1 Erosive and ulcerative plaques on the right dorsal hand. (A) At presentation. (B)
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were suspected; therefore, serological tests were performed.
Enzyme-linked immunosorbent assay (ELISA) screening test
revealed positivity to anti-HTLV I/II, and reactivity to HTLV type I
(HTLV-I) was conﬁrmed by Western blot analysis.Ten days before the initiation of chemotherapy. (C) Four months after chemotherapy.
n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 3 Inﬁltration of atypical medium-sized lymphocytes with nuclear pleomor-
phism and some eosinophils in the dermis (hematoxylin and eosin, 400).
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Based on the abovementioned ﬁndings, a diagnosis of adult T cell
lymphoma was made.
Discussion
Adult T cell lymphoma/leukemia (ATLL) is a malignant lymphopro-
liferative disease caused by HTLV-I. HTLV-I infection is endemic in
southern Japan, the Caribbean Islands, South America, and possibly
some areas of northern Taiwan.1 More than 90% of infected persons
are asymptomatic carriers.2 Mother-to-infant (mainly through
breast feeding), sexual intercourse, and blood transfusion are the
main modes of transmission.2 More than 50% of patients with
ATLL present with skin rashes. Inﬁltration of atypical lymphocytes
into the epidermis and dermal perivascular areas with Pautrier-
like microabscesses are common ﬁndings.3 Clinical and histological
ﬁndings can lead to confusion betweenmycosis fungoides (MF) and
ATLL; however, Western blot and polymerase chain reaction (PCR)
are sensitive and speciﬁc means of determining the type of HTLV
infection.4 In the current case, Western blot assay, which was per-
formed according to the instructions provided in the MP Diagnos-
tics HTLV Blot 2.4 kit (MP Biomedicals, Solon, Ohio, USA), was
used to identify antibodies speciﬁc to HTLV-1 in blood samples.
Seropositivity to the group-speciﬁc antigen (p19) and two envelope
proteins (GD21 and rgp46-I) were also noted.
Clinically, there are four indentiﬁed subtypes of ATLL: acute,
lymphomatous, chronic, and smoldering.3 The most appropriate
treatment for ATLL depends on the patient’s clinical subtype. In
patients with the acute or lymphomatous subtypes, different combi-
nations of conventional chemotherapy are used. However, most of
these patients experience relapse within weeks or months, and the
4-year survival rate is<5%.5 In some cases, combination therapy con-
sisting of interferon and zidovudine can be effective.2 The use of allo-
geneic hematopoietic stem cell transplantation in selected patients
has also demonstrated improved clinical outcomes.5 However, the
reported incidences of transplantation-related mortality remains
high.5 The major prognostic factors include clinical subtype, age,
performance status, and serum calcium and LDH levels. The major
causes of deathof patientswith the acute or lymphomatous subtypes
are often related to opportunistic infections. The chronic and smol-
dering subtypes demonstrate better reported clinical courses and
better survival rates, but these subtypes can develop into acute
conditions that can be aggressive and difﬁcult to treat.2
In the current patient, the ulcerative plaques on his hand rapidly
progressed todeeper lesions; thoseonhis solesprogressed to fungat-
ing lesions. These were extremely painful after hospitalization
(Figures 1B and 2B, C). Soon after being diagnosed with ATLL,
his hematologist initiated conventional chemotherapy with cyclo-
phosphamide, doxorubicin, etoposide, vincristine and prednisone
(CHOEP). Deterioration of the ulcerative wounds slowed and halted,
then thewounds gradually started to heal.His serumLDH level drop-
ped to 167 U/L. Four months after initiating chemotherapy, all of the
ulcers had completely healed (Figures 1C and 2D), though a few
papules relapsed and remained throughout the course of treatment.
During the same period, there was no evidence of psoriasiform
lesions.However, persistent intensepruritus caused thepatientgreat
discomfort, despite the administration of oral antihistamines, topical
steroids, and narrow-band ultraviolet B therapy. Anticonvulsants,
antidepressants, and antiemetic drugs (aprepitant) are alternative
antipruritic agents that are reportedly helpful for the treatment of
recalcitrantpruritus in associationwith cutaneousTcell lymphoma;6
however, the current patient did not accept these medications.
Despite his clinical history of psoriasis, the skin rashes were actually
manifestations of ATLL. Case reports have described thedevelopment of ATLL in patients with psoriasis who have received
methotrexate or cyclosporine treatment.7,8 However, the current
patient had not taken any of these immunosuppressive drugs.
In conclusion, in patients with indeterminate rashes that display
variable severity and recalcitrant pruritus, careful histological
examination should be conducted to eliminate cutaneous T cell
lymphoma or other possible diseases.
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